Resolvin D1 values in patients with alcohol-associated liver disease
Serum RvD1 levels are associated with the severity of ALD and may represent a promising non-invasive biomarker. However, due to the absence of an external validation cohort, these findings should be interpreted as exploratory. Further validation in independent populations is warranted to confirm the clinical utility of RvD1 in ALD.
Authors
- İrfan Küçük (ORCID: https://orcid.org/0000-0001-7449-8276)
- Musa Salmanoğlu (ORCID: https://orcid.org/0000-0002-5050-531X)
- Süleyman Baş (ORCID: https://orcid.org/0000-0002-5883-445X)
Institutions
- University of Health Science (KH)
- Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Universidad CES (CO)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12876-025-04221-2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00